These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2252686)

  • 1. Backdiffusion rather than backfiltration enhances endotoxin transport through highly permeable dialysis membranes.
    Hosoya N; Sakai K
    ASAIO Trans; 1990; 36(3):M311-3. PubMed ID: 2252686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin transfer through dialysis membranes: small- versus large-pore membranes.
    Vanholder R; Van Haecke E; Veys N; Ringoir S
    Nephrol Dial Transplant; 1992; 7(4):333-9. PubMed ID: 1317524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes.
    Leypoldt JK; Schmidt B; Gurland HJ
    Artif Organs; 1991 Jun; 15(3):164-70. PubMed ID: 1907821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On line filtration of dialysate: structural and functional features of an asymmetric polysulfone hollow fiber ultrafilter (Diaclean).
    Ronco C; Cappelli G; Ballestri M; Lusvarghi E; Frisone P; Milan M; Dell'Aquila R; Crepaldi C; Dissegna D; Gastaldon F
    Int J Artif Organs; 1994 Oct; 17(10):515-20. PubMed ID: 7896424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of EPO therapy on backfiltration of dialysate in high flux dialysis.
    Robertson BC; Curtin C
    ASAIO Trans; 1990; 36(3):M447-52. PubMed ID: 2252724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
    Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
    Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simulation of continuous arteriovenous hemodialysis with a mathematical model.
    Pallone TL; Hyver S; Petersen J
    Kidney Int; 1989 Jan; 35(1):125-33. PubMed ID: 2709658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of backfiltration rates during hemodialysis with highly permeable membranes.
    Leypoldt JK; Schmidt B; Gurland HJ
    Blood Purif; 1991; 9(2):74-84. PubMed ID: 1760145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes.
    Baurmeister U; Travers M; Vienken J; Harding G; Million C; Klein E; Pass T; Wright R
    ASAIO Trans; 1989; 35(3):519-22. PubMed ID: 2597523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes.
    Pereira BJ; Snodgrass BR; Hogan PJ; King AJ
    Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrogen transfer across high- and low-flux hemodialysis membranes.
    Weber V; Linsberger I; Rossmanith E; Weber C; Falkenhagen D
    Artif Organs; 2004 Feb; 28(2):210-7. PubMed ID: 14961961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New generation ceramic membranes have the potential of removing endotoxins from dialysis water and dialysate.
    Czermak P; Ebrahimi M; Catapano G
    Int J Artif Organs; 2005 Jul; 28(7):694-700. PubMed ID: 16049903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrapure dialysate: facts and myths.
    Bommer J; Jaber BL
    Semin Dial; 2006; 19(2):115-9. PubMed ID: 16551288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin adsorption of various dialysis membranes: in vitro study.
    Takemoto Y; Nakatani T; Sugimura K; Yoshimura R; Tsuchida K
    Artif Organs; 2003 Dec; 27(12):1134-7. PubMed ID: 14678429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.